LOC653501 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.51450005051402E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.77469999701674E-08 |
Normal-vs-Stage2 |
2.23370000052014E-07 |
Normal-vs-Stage3 |
1.43700000010405E-07 |
Normal-vs-Stage4 |
3.91410000000203E-06 |
Stage1-vs-Stage2 |
3.937800E-01 |
Stage1-vs-Stage3 |
3.127000E-01 |
Stage1-vs-Stage4 |
2.492400E-01 |
Stage2-vs-Stage3 |
6.997200E-01 |
Stage2-vs-Stage4 |
6.473400E-01 |
Stage3-vs-Stage4 |
9.397800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.91529999638007E-08 |
Normal-vs-AfricanAmerican |
6.49860000256908E-08 |
Normal-vs-Asian |
5.788500E-04 |
Caucasian-vs-AfricanAmerican |
5.106400E-01 |
Caucasian-vs-Asian |
5.117000E-01 |
AfricanAmerican-vs-Asian |
5.557400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.08349995642243E-09 |
Normal-vs-Female |
1.758190E-04 |
Male-vs-Female |
7.407700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.80140000000306E-05 |
Normal-vs-Extreme_Weight |
3.89220000673873E-09 |
Normal-vs-Obese |
1.82583999999153E-05 |
Normal-vs-Extreme_Obese |
1.219330E-04 |
Normal_Weight-vs-Extreme_Weight |
3.175400E-01 |
Normal_Weight-vs-Obese |
8.872200E-01 |
Normal_Weight-vs-Extreme_Obese |
6.346800E-01 |
Extreme_Weight-vs-Obese |
2.111400E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.252200E-01 |
Obese-vs-Extreme_Obese |
5.862800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.57300000486794E-08 |
Normal-vs-Age(41-60Yrs) |
4.62580000004653E-06 |
Normal-vs-Age(61-80Yrs) |
7.88820009312019E-10 |
Normal-vs-Age(81-100Yrs) |
1.087920E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.616000E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.874800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.341800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.220400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.085600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.945200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.75180000014674E-07 |
Normal-VS-Type2 PRCC |
2.89390000851597E-09 |
Normal-VS-KIRP CIMP |
3.17269999161596E-09 |
Normal-VS-Unclassified PRCC |
3.96350000000378E-05 |
Type1 PRCC-VS-Type2 PRCC |
2.207700E-02 |
Type1 PRCC-VS-KIRP CIMP |
2.22779999999867E-05 |
Type1 PRCC-VS-Unclassified PRCC |
6.127600E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.462900E-03 |
Type2 PRCC-VS-Unclassified PRCC |
2.461400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.595400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.47270023637725E-11 |
Normal-vs-N1 |
2.36450000024035E-07 |
Normal-vs-N2 |
1.81074999999753E-05 |
N0-vs-N1 |
8.595200E-01 |
N0-vs-N2 |
1.167430E-01 |
N1-vs-N2 |
2.445600E-01 |
|
|